Maxcyte (MXCT) Debt to Equity (2020)
Maxcyte (MXCT) has disclosed Debt to Equity for 1 consecutive years, with $0.15 as the latest value for Q4 2020.
- On a quarterly basis, Debt to Equity changed N/A to $0.15 in Q4 2020 year-over-year; TTM through Dec 2020 was $0.15, a N/A change, with the full-year FY2020 number at $0.15, changed N/A from a year prior.
- Debt to Equity was $0.15 for Q4 2020 at Maxcyte.
- In the past five years, Debt to Equity ranged from a high of $0.15 in Q4 2020 to a low of $0.15 in Q4 2020.